CagriSema, at least in its current clinical development program, targets a single maintenance dose of 2.4/2.4 mg, offering less room for individualization
Use should occur only under qualified physician supervision with peptides sourced from licensed compounding pharmacies
Older adults (60+) May benefit from extended escalation intervals (6 weeks per step instead of 4) due to: Slower metabolic adaptation Increased medication sensitivity Higher likelihood of comorbid conditions Potential polypharmacy interactions Body Weight and Composition Factors Unlike some medications dosed per kilogram of body weight, cagrilintide uses fixed dosing regardless of baseline weight
Benzyl Alcohol, 1.5%, is present as a preservative
Review meds (e.g., metformin, PPIs), medical conditions (GI surgery, malabsorption), and diet with your clinician
Use the Peptide Reconstitution Calculator to determine exact volumes for your chosen vial size